Phantom Stopgap PDUFA Renewal Might Prompt Faster FDARA Action
This article was originally published in The Tan Sheet
Executive Summary
A proposal apparently circulated by House Democratic leaders to renew user fee programs for three months while negotiations on FDA reform legislation continue is "not an option," Sen. Michael Enzi, R-Wyo., ranking member of the Health, Education, Labor and Pensions Committee, has declared
You may also be interested in...
FDA Reauthorization Steers Clear Of Agency’s OTC Authority, DSHEA, AER Law
The FDA reauthorization bill Congress has passed does not rock the boat on FDA's current authority over either over-the-counter switches or dietary supplements
FDA Reauthorization Steers Clear Of Agency’s OTC Authority, DSHEA, AER Law
The FDA reauthorization bill Congress has passed does not rock the boat on FDA's current authority over either over-the-counter switches or dietary supplements
FDA Reauthorization Steers Clear Of Agency’s OTC Authority, DSHEA, AER Law
The FDA reauthorization bill Congress has passed does not rock the boat on FDA's current authority over either over-the-counter switches or dietary supplements